These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 576165)

  • 1. Measles immunization. Successes and failures.
    Yeager AS; Davis JH; Ross LA; Harvey B
    JAMA; 1977 Jan; 237(4):347-51. PubMed ID: 576165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children.
    Arpadi SM; Markowitz LE; Baughman AL; Shah K; Adam H; Wiznia A; Lambert G; Dobroszycki J; Heath JL; Bellini WJ
    Pediatrics; 1996 May; 97(5):653-7. PubMed ID: 8628602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transplacental measles immunity in infants in the 1st year of life].
    Bystriakova LV; Zaĭtseva RV; Kolobova LV; Pushkareva EA; Smorodinova IP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):50-2. PubMed ID: 1839342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Need for measles revaccination in adolescents: correlation with birth date prior to 1972.
    Yeager AS; Harvey B; Crosson FJ; Davis JH; Ross LA; Halonen PE
    J Pediatr; 1983 Feb; 102(2):191-5. PubMed ID: 6822921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines.
    Sabin AB; Flores Arechiga A; Fernández de Castro J; Sever JL; Madden DL; Shekarchi I; Albrecht P
    JAMA; 1983 May; 249(19):2651-62. PubMed ID: 6341638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles reimmunization in children seronegative after initial immunization.
    Poland GA; Jacobson RM; Thampy AM; Colbourne SA; Wollan PC; Lipsky JJ; Jacobsen SJ
    JAMA; 1997 Apr; 277(14):1156-8. PubMed ID: 9087472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimum age for measles immunisation: study of pre- and post-immunization level of HI antibody titres.
    Bhatnagar SK; Mohan M; Kumar P; Balaya S; Prabhakar AK; Bhargava SK
    Indian Pediatr; 1981 Sep; 18(9):625-9. PubMed ID: 6797943
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological effectiveness of a booster inoculation against measles in children remaining seronegative after vaccination].
    Bolomovskiĭ VM; Gelikman BG; Titova NS; Slavnitskaia IV; Auzinia AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):100-6. PubMed ID: 6333122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure.
    Albrecht P; Ennis FA; Saltzman EJ; Krugman S
    J Pediatr; 1977 Nov; 91(5):715-8. PubMed ID: 909009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles revaccination. Persistence and degree of antibody titer by type of immune response.
    Deseda-Tous J; Cherry JD; Spencer MJ; Welliver RC; Boyer KM; Dudley JP; Zahradnik JM; Krause PJ; Walbergh EW
    Am J Dis Child; 1978 Mar; 132(3):287-90. PubMed ID: 629246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles (rubeola) susceptibility among elementary schoolchildren.
    Kalis JM; Quie PG; Balfour HH
    Am J Epidemiol; 1975 Jun; 101(6):527-31. PubMed ID: 1155431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of measles hemagglutination inhibiting antibody levels among school children in Ibadan, Nigeria.
    Ogundiji OT; Okonko IO; Adu FD
    J Immunoassay Immunochem; 2013; 34(2):208-17. PubMed ID: 23537304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Duration of the preservation of postvaccinal immunity against measles and the results of a repeat immunization of children with various initial antibody levels].
    Sokhin AA; Sliusar' LI; Popov VF; Noskov FS; Radomskaia FS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):79-85. PubMed ID: 6637278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological survey of measles in Yemen in 1985.
    Strauss J; Dobahi SS; Danes L; Kopecký K; Svandová E
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(1):71-4. PubMed ID: 2723425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.